Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06287177 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy

Study acronym: CHOLINET
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: 1000 to 3000
    • Study completion date: Nov 1, 2024 to Nov 1, 2030
    v3
  2. Primary completion date: Feb 1, 2024 to Feb 29, 2024
    • Study completion date: Feb 1, 2025 to Nov 1, 2024
    • Start date: Feb 1, 2023 to Nov 1, 2022
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population
Trial Details
NCT Number NCT06287177
Lead Sponsor Federico II University
Conditions
(from sponsor)		 Hypercholesterolemia
Related terms Hypercholesterolemia
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov